Fingolimod granted FDA Breakthrough Therapy designation for paediatric MS
Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for fingolimod for the treatment of children and adolescents 10 years of age or older with relapsing multiple sclerosis (MS)...Read more - http://www.ms-uk.org/fingolimod-granted ... diatric-ms
Fingolimod granted FDA Breakthrough Therapy designation...
Fingolimod granted FDA Breakthrough Therapy designation...
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2146 Views
-
Last post by frodo
-
- 0 Replies
- 9754 Views
-
Last post by NHE
-
- 2 Replies
- 1609 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1778 Views
-
Last post by Petr75
-
- 0 Replies
- 1207 Views
-
Last post by NHE
-
- 2 Replies
- 1851 Views
-
Last post by frodo
-
- 0 Replies
- 10613 Views
-
Last post by NHE
-
- 0 Replies
- 2485 Views
-
Last post by frodo
-
- 0 Replies
- 2565 Views
-
Last post by NHE